We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Alliance Pharma Plc | LSE:APH | London | Ordinary Share | GB0031030819 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.05 | 0.14% | 34.95 | 34.85 | 35.00 | 35.75 | 34.45 | 35.75 | 330,994 | 16:35:09 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 167.42M | 936k | 0.0017 | 205.88 | 189.05M |
TIDMAPH TIDMAV.
RNS Number : 5091P
Alliance Pharma PLC
17 November 2016
Hot Features
Premium
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
------------------------------------------------------------------------------------------------------------
1. Identity of the issuer or Alliance Pharma plc
the underlying issuer
of existing shares to which
voting rights are
attached:
--------------------------------------------------------------- -------------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
------------------------------------------------------------------- ---------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------------- ---------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------------- ---------------------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------------- ---------------------------------------
Other (please
specify):
----------------------------------------------------------- ------ ---------------------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
------------------------------------------------------------- ---------------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):
Available on request 18,450*
BNY Norwich Union Nominees
Limited 2,744,814*
Chase (GA Group) Nominees
Limited 38,963,722*
*denotes direct interest
Chase Nominees Limited 1,382,120
------------------------------------------------------------- ---------------------------------------------
5. Date of the transaction 15 November 2016
and date on
which the threshold is
crossed or
reached:
------------------------------------------------------------- ---------------------------------------------
6. Date on which issuer 16 November 2016
notified:
------------------------------------------------------------- ---------------------------------------------
7. Threshold(s) that is/are 9% to 8% Change at Direct
crossed or Interest Level (Box 8A)
reached:
------------------------------------------------------------- ---------------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
--------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
---------------- ------------------------------ ------------------------------------------------------------
Number Number Number Number of voting % of voting
of of of shares rights rights
Shares Voting
Rights
---------------- ---------------- ------------ ------------- ------------------------ -------------------
Direct Direct Indirect Direct Indirect
---------------- ---------------- ------------ ------------- ----------- ----------- ------- ----------
Ordinary
Shares
GB0031030819 45,033,531* 45,033,531* 43,109,106 41,726,986 1,382,120 8.86% 0.29%
---------------- ------------ ------------- ----------- ----------- ------- ----------
* Includes Right to Recall Loaned Shares (1,080,000)
--------------------------------------------------------------------------------------------------------------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument Period may be
acquired if
the
instrument
is
exercised/
converted.
---------------- ---------------- --------------------------- ------------------------ -------------------
1,132,875*
RIGHT TO RECALL
LOANED SHARES N/A N/A *Direct Interest 0.24%
---------------- ---------------- --------------------------- ------------------------ -------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights
period refers to
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
44,241,981 9.39%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
----------------------------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited and Friends Provident
International Limited, with the following chain of controlled
undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Friends Provident International Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Life Holdings UK Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Friends Life FPG Limited (wholly owned subsidiary of
Aviva Life Holdings UK Limited)
* Friends Life FPL Limited (wholly owned subsidiary of
Friends Life FPG Limited)
* Friends Life Limited (wholly owned subsidiary of
Friends Life FPL Limited)
* Friends Life and Pensions Limited (wholly owned
subsidiary of Friends Life Limited)
* Friends Provident International Limited (wholly owned
subsidiary of Friends Life and Pensions Limited)
Proxy Voting:
----------------------------------------------------------------------------------
10. Name of the proxy holder: See Section 4
-------------------------------------------------- ------------------------------
11. Number of voting rights proxy
holder will cease to hold:
-------------------------------------------------- ------------------------------
12. Date on which proxy holder will
cease to hold voting rights:
-------------------------------------------------- ------------------------------
13. Additional information: Figures are based on a total
number of voting rights of
471,113,833.
-------------------------------------------------- ------------------------------
14. Contact name: Neil Whittaker, Aviva plc
-------------------------------------------------- ------------------------------
15. Contact telephone number: 01603 684420
-------------------------------------------------- ------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAXFXFEFKFFF
(END) Dow Jones Newswires
November 17, 2016 12:05 ET (17:05 GMT)
1 Year Alliance Pharma Chart |
1 Month Alliance Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
